Somaxon Pharmaceuticals (SOMX) Files $75M Mixed Securities Shelf
More News related to SOMX
- Somaxon (SOMX) Volatile Into FDA Action Date
- InvestorSoup.com Initiates Independent Research Coverage on Somaxon Pharmaceuticals Inc.
- Unusual 11 Mid-Day Movers 11/30: SOMX, CLWT, KBX, CSGS Higher; AIG, BGP, BONT, HEB Lower
- Somaxon Pharmaceuticals (SOMX) Surges Ahead of FDA Action Date
- Morning Movers 11/30: PEIX, CLRT, PROV, SOMX, OTIV Higher; HPOL, MELA Lower
More News related to Equity Offerings
- BofA (BAC) Sells 1.286B Common Equivalent Securities at $15
- Puda Coal (PUDA) Files 191.3K Common Shelf For Selling Shareholders
- Bank of America (BAC) Raises $19.3B By Selling 'Common Equivalent Securities' at $15
- Home Properties (HME) Initiates 3.7M Common ATM Program
- SWS Group (SWS) Prices 4.35M Common Offering at $11.50/Share
After the close Friday, Somaxon Pharmaceuticals (Nasdaq: SOMX) filed to offer up to $75 million in various securities on Form S-3 with the SEC. The company may sell debt, preferred stock, common stock, debt and equity warrants.
Related Categories
Equity OfferingsStocks Mentioned
-0.58Related Entities
Sign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
